Expanded Access to Convalescent Plasma for the Treatment of Patients with COVID-19 Save

Date Added
April 16th, 2020
PRO Number
Pro00099382
Researcher
John Wrangle

List of Studies

Silhouette
Keywords
Infectious Diseases
Summary

People who recover from COVID-19 do so, at least in part, because their blood contains substances called antibodies, which are capable of fighting the virus that causes the illness. It turns out that for some other diseases caused by respiratory viruses, giving people the liquid portion of blood, called plasma, obtained from those who have recovered from the virus, leads to more rapid improvement of the disease. This study hopes to investigate if patients with COVID-19 improve faster if they receive plasma from those who have recovered from COVID-19.

Institution
MUSC
Recruitment Contact
Ashley Warden
8437924349
jonesash@musc.edu

Change_preferences

-- OR --

Create_login